BioLife Sciences Inc.
BLFEOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$156683
P/E Ratio—
52W High$0.0001
52W Low$0.0001
BioLife Sciences Inc. (BLFE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BLFE · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2020-11 | 2019-11 | 2018-11 | 2017-11 | 2016-11 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.41M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $1.40M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | ($0.98M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | -239.25% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $0.26M | $0.00M | $0.04M | $0.33M | $0.01M |
| Operating Income | ($1.24M) | $0.00M | ($0.04M) | ($0.33M) | ($0.01M) |
| Operating Margin %(computed) | -302.17% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.05M | $0.00M | $0.01M | $0.01M | $0.01M |
| Income Before Tax | ($1.27M) | ($0.00M) | ($0.05M) | ($0.34M) | ($0.02M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($1.27M) | ($0.00M) | ($0.05M) | ($0.34M) | ($0.02M) |
| Net Margin %(computed) | -307.99% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.00 | $-0.00 | $-0.08 | $-0.05 |
| Wtd Avg Shares | 51.78M | 19.45M | 19.45M | 4.45M | 0.42M |
| EBITDA | ($1.22M) | $0.17M | ($0.04M) | ($0.33M) | ($0.01M) |
| EBITDA Margin %(computed) | -295.95% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more BioLife Sciences Inc. data
About BioLife Sciences Inc. (BLFE) Income Statement
BioLife Sciences Inc. (BLFE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2020, BLFE reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -239.25%), and net income of ($0.00B) — a net profit margin of -307.99%.
Frequently asked questions
BLFE · 4 questionsBioLife Sciences Inc. (BLFE) reported revenue of $0.00B for 2020, up —% year-over-year.
BLFE revenueBLFE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09